Comment on

• Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

  Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG. Trovo M, et al. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012. Int J Radiat Oncol Biol Phys. 2014. PMID: 24661664
• Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.

  Sun B, Brooks ED, Komaki R, Liao Z, Jeter M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, Hahn SM, Sepesi B, Rice DC, Heymach JV, Chang JY. Sun B, et al. J Thorac Oncol. 2017 Jun;12(6):983-992. doi: 10.1016/j.jtho.2017.02.018. Epub 2017 Mar 1. J Thorac Oncol. 2017. PMID: 28259750 Free PMC article. Clinical Trial.
• Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.

  Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT. Repka MC, et al. Radiat Oncol. 2017 Oct 19;12(1):162. doi: 10.1186/s13014-017-0897-6. Radiat Oncol. 2017. PMID: 29052514 Free PMC article.
• Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field.

  Horne ZD, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Horne ZD, et al. Pract Radiat Oncol. 2018 May-Jun;8(3):e117-e123. doi: 10.1016/j.prro.2017.11.011. Epub 2017 Dec 8. Pract Radiat Oncol. 2018. PMID: 29724402
• Effectiveness and Safety of Reirradiation With Stereotactic Ablative Radiotherapy of Lung Cancer After a First Course of Thoracic Radiation: A Meta-analysis.

  Viani GA, Arruda CV, De Fendi LI. Viani GA, et al. Am J Clin Oncol. 2020 Aug;43(8):575-581. doi: 10.1097/COC.0000000000000709. Am J Clin Oncol. 2020. PMID: 32554982